Progress in therapy across the spectrum of advanced prostate cancer

Sabine Schmid; Aurelius Omlin

首页> 外文期刊>Nature reviews. Urology >Progress in therapy across the spectrum of advanced prostate cancer

【24h】

Progress in therapy across the spectrum of advanced prostate cancer

机译：跨越晚期前列腺癌谱的治疗进展

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

In men with hormone-sensitive prostate cancer, enzalutamide and apalutamide improve overall survival compared with androgen deprivation therapy alone. Also, radiotherapy of the primary tumour is beneficial in patients with low tumour burden. In the non-metastatic castration-resistant setting, a positive trial for darolutamide was reported. In the metastatic castration-resistant setting, the role of cabazitaxel in treatment sequencing was clarified.

机译：在具有激素敏感的前列腺癌的男性中，与单独的雄激素剥夺治疗相比，烯甲酰胺和奥氟胺酰胺改善整体存活。此外，原发性肿瘤的放射疗法有益于肿瘤负担低的患者。在非转移性阉割抗旋转装置中，报道了多谷氨酰胺的阳性试验。在转移性阉割抵抗设定中，阐明了Cabazitaxel在处理测序中的作用。

著录项

来源
《Nature reviews. Urology》 |2020年第2期|共2页
作者
Sabine Schmid; Aurelius Omlin;
展开▼
作者单位

10000 0001 2294 4705grid.413349.8Department of Medical Oncology and HematologyCantonal Hospital St;

10000 0001 2294 4705grid.413349.8Department of Medical Oncology and HematologyCantonal Hospital St;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Progress in therapy across the spectrum of advanced prostate cancer [J] . Sabine Schmid, Aurelius Omlin Nature reviews. Urology . 2020,第2期

机译：跨越晚期前列腺癌谱的治疗进展
2. Chemotherapy at First Diagnosis of Advanced Prostate Cancer - Revolution or Evolution? Findings from a British Uro-oncology Group UK Survey to Evaluate Oncologists' Views on First-line Docetaxel in Combination with Androgen Deprivation Therapy in Castrate-sensitive Metastatic and High-risk/Locally Advanced Prostate Cancer [J] . Davda R., Hughes S., Jones R., Clinical oncology . 2016,第6期

机译：晚期前列腺癌首次诊断时的化学疗法-革命还是进化？从英国泌尿肿瘤学团体英国调查中发现的结果，以评估肿瘤学家对一线多西紫杉醇联合雄激素剥夺疗法联合治疗去势敏感的转移性和高危/局部晚期前列腺癌的观点
3. Chemotherapy at First Diagnosis of Advanced Prostate Cancer - Revolution or Evolution? Findings from a British Uro-oncology Group UK Survey to Evaluate Oncologists' Views on First-line Docetaxel in Combination with Androgen Deprivation Therapy in Castrate-sensitive Metastatic and High-risk/Locally Advanced Prostate Cancer [J] . Davda R., Hughes S., Jones R., Clinical oncology . 2016,第6期

机译：在第一次诊断晚期前列腺癌的化疗 - 革命还是演变？英国Uro-Moycology Group Group US调查的调查结果评估肿瘤学系的肿瘤学家的看法与雄激素剥夺的转移和高风险/局部晚期前列腺癌的雄激素剥夺治疗组合
4. Thermal Dosimetry Analysis Combined with Patient-specific Thermal Modeling of Clinical Interstitial Ultrasound Hyperthermia Integrated within HDR Brachytherapy for Treatment of Locally Advanced Prostate Cancer [C] . Vasant A. Salgaonkar, Jeff Wootton, Punit Prakash, International Symposium on Therapeutic Ultrasound . 2017

机译：热量剂量分析结合患者特异性热建模临床间质超热疗，整合在HDR近距离放射治疗中治疗局部晚期前列腺癌
5. New Candidate Cancer Genes and Combination Therapy for Advanced Prostate Cancer. [D] . Le, Bao. 2017

机译：新的候选癌基因和晚期前列腺癌的联合治疗。
6. Vorinostat in Advanced Prostate Cancer Patients Progressing on Prior Chemotherapy (NCI Trial # 6862): Trial results and IL-6 analysis. A study by the DOD Prostate Cancer Clinical Trial Consortium and University of Chicago Phase II Consortium [O] . Deborah Bradley, Dana Rathkopf, Rodney Dunn, -1

机译：vorinostat在晚期前列腺癌患者进展前化学疗法（NCI试验＃6862）：试验结果和IL-6分析。国防部前列腺癌临床试验联盟和芝加哥二期联盟大学的研究
7. Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862) [O] . Bradley, Deborah, Rathkopf, Dana, Dunn, Rodney, 2009

机译：Vorinostat治疗晚期前列腺癌患者的化疗进展（国家癌症研究所试验6862）

Progress in therapy across the spectrum of advanced prostate cancer

摘要

著录项

相似文献

相关主题

期刊订阅